AA

ALPS Advisors Portfolio holdings

AUM $18B
1-Year Est. Return 16.79%
This Quarter Est. Return
1 Year Est. Return
+16.79%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$17.3B
AUM Growth
+$91.5M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
1,066
New
Increased
Reduced
Closed

Top Buys

1
+$100M
2
+$99.4M
3
+$41.5M
4
WES icon
Western Midstream Partners
WES
+$32.9M
5
IVV icon
iShares Core S&P 500 ETF
IVV
+$28.1M

Top Sells

1
+$32.7M
2
+$20.4M
3
+$19.4M
4
FNDA icon
Schwab Fundamental US Small Company Index ETF
FNDA
+$17M
5
FNDF icon
Schwab Fundamental International Large Company Index ETF
FNDF
+$13.4M

Sector Composition

1 Energy 68.28%
2 Technology 4.29%
3 Financials 3.4%
4 Consumer Discretionary 2.95%
5 Materials 2.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IRWD icon
1026
Ironwood Pharmaceuticals
IRWD
$522M
– –
-116,860
JWN
1027
DELISTED
Nordstrom
JWN
– –
-28,250
LQDA icon
1028
Liquidia Corp
LQDA
$2.99B
– –
-62,656
LRMR icon
1029
Larimar Therapeutics
LRMR
$327M
– –
-47,460
MAG
1030
DELISTED
MAG Silver
MAG
– –
-392,675
MGNX icon
1031
MacroGenics
MGNX
$102M
– –
-48,646
MLYS icon
1032
Mineralys Therapeutics
MLYS
$2.94B
– –
-34,664
NAK
1033
Northern Dynasty Minerals
NAK
$1.11B
– –
-1,308,007
NMRA icon
1034
Neumora Therapeutics
NMRA
$302M
– –
-114,371
NTLA icon
1035
Intellia Therapeutics
NTLA
$1.06B
– –
-77,328
PLD icon
1036
Prologis
PLD
$120B
– –
-3,809
PLL
1037
DELISTED
Piedmont Lithium
PLL
– –
-33,637
ACRS icon
1038
Aclaris Therapeutics
ACRS
$328M
– –
-78,782
ALDX icon
1039
Aldeyra Therapeutics
ALDX
$319M
– –
-43,803
ALEC icon
1040
Alector
ALEC
$158M
– –
-74,933
AMLX icon
1041
Amylyx Pharmaceuticals
AMLX
$1.34B
– –
-67,597
ATLX icon
1042
Atlas Lithium Corp
ATLX
$122M
– –
-10,779
AURA icon
1043
Aura Biosciences
AURA
$373M
– –
-37,156
CIB icon
1044
Grupo Cibest SA
CIB
$15.5B
– –
-11,894
CRGX
1045
DELISTED
CARGO Therapeutics
CRGX
– –
-33,158
DAR icon
1046
Darling Ingredients
DAR
$5.69B
– –
-136,520
DEA
1047
Easterly Government Properties
DEA
$983M
– –
-10,184
ELDN icon
1048
Eledon Pharmaceuticals
ELDN
$120M
– –
-44,436
ENTA icon
1049
Enanta Pharmaceuticals
ENTA
$474M
– –
-16,257
FDMT icon
1050
4D Molecular Therapeutics
FDMT
$455M
– –
-32,811
39 40 41
42
43